Global Capsule Endoscopy
Market Report
2025
The global Capsule Endoscopy market size will be USD 491.6 million in 2024. Rising cancer prevalence, a growing global elderly population, increasing rates of gastrointestinal disorders, expanding awareness of non-invasive diagnostic technologies, and heightened investments in healthcare infrastructure are expected to boost sales to USD 945.86 million by 2031, with a Compound Annual Growth Rate (CAGR) of 9.80% from 2024 to 2031.
The base year for the calculation is 2023 and 2019 to 2023 will be historical period. The year 2024 will be estimated one while the forecasted data will be from year 2025 to 2031. When we deliver the report that time we updated report data till the purchase date.
PDF Access: Password protected PDF file, Excel File Access: Quantitative data, PPT Report Access: For the presentation purpose, Cloud Access: Secure Company Account Access.
Share your contact details to receive free updated sample copy/pages of the recently published edition of Capsule Endoscopy Market Report 2024.
According to Cognitive Market Research, the global Capsule Endoscopy market size will be USD 491.6 million in 2024. It will expand at a compound annual growth rate (CAGR) of 9.80% from 2024 to 2031.
Base Year | 2023 |
Historical Data Time Period | 2019-2023 |
Forecast Period | 2024-2031 |
Global Capsule Endoscopy Market Sales Revenue 2024 | $ 491.6 Million |
Global Capsule Endoscopy Market Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.8% |
North America Capsule Endoscopy Sales Revenue 2024 | $ 196.64 Million |
North America Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8% |
United States Capsule Endoscopy Sales Revenue 2024 | $ 155.15 Million |
United States Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.8% |
Canada Capsule Endoscopy Sales Revenue 2024 | $ 23.6 Million |
Canada Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.8% |
Mexico Capsule Endoscopy Sales Revenue 2024 | $ 17.89 Million |
Mexico Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.5% |
Europe Capsule Endoscopy Sales Revenue 2024 | $ 147.48 Million |
Europe Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.3% |
United Kingdom Capsule Endoscopy Sales Revenue 2024 | $ 24.78 Million |
United Kingdom Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.1% |
France Capsule Endoscopy Sales Revenue 2024 | $ 13.57 Million |
France Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.5% |
Germany Capsule Endoscopy Sales Revenue 2024 | $ 29.2 Million |
Germany Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.5% |
Italy Capsule Endoscopy Sales Revenue 2024 | $ 12.68 Million |
Italy Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.7% |
Russia Capsule Endoscopy Sales Revenue 2024 | $ 22.86 Million |
Russia Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.3% |
Spain Capsule Endoscopy Sales Revenue 2024 | $ 12.09 Million |
Spain Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7.4% |
Rest of Europe Capsule Endoscopy Sales Revenue 2024 | $ 22.86 Million |
Rest of Europe Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 7% |
Asia Pacific Capsule Endoscopy Sales Revenue 2024 | $ 113.07 Million |
Asia Pacific Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 11.8% |
China Capsule Endoscopy Sales Revenue 2024 | $ 50.88 Million |
China Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 11.3% |
Japan Capsule Endoscopy Sales Revenue 2024 | $ 15.6 Million |
Japan Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.3% |
Korea Capsule Endoscopy Sales Revenue 2024 | $ 11.31 Million |
Korea Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.9% |
India Capsule Endoscopy Sales Revenue 2024 | $ 13.57 Million |
India Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 13.6% |
Australia Capsule Endoscopy Sales Revenue 2024 | $ 5.88 Million |
Australia Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 11.5% |
Rest of APAC Capsule Endoscopy Sales Revenue 2024 | $ 8.03 Million |
Rest of APAC Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 11.6% |
South America Capsule Endoscopy Sales Revenue 2024 | $ 24.58 Million |
South America Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.2% |
Brazil Capsule Endoscopy Sales Revenue 2024 | $ 10.52 Million |
Brazil Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.8% |
Argentina Capsule Endoscopy Sales Revenue 2024 | $ 4.13 Million |
Argentina Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.1% |
Colombia Capsule Endoscopy Sales Revenue 2024 | $ 2.19 Million |
Colombia Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9% |
Peru Capsule Endoscopy Sales Revenue 2024 | $ 2.02 Million |
Peru Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.4% |
Chile Capsule Endoscopy Sales Revenue 2024 | $ 1.77 Million |
Chile Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.5% |
Rest of South America Capsule Endoscopy Sales Revenue 2024 | $ 3.96 Million |
Rest of South America Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.3% |
Middle East and Africa Capsule Endoscopy Sales Revenue 2024 | $ 9.83 Million |
Middle East and Africa Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.5% |
Turkey Capsule Endoscopy Sales Revenue 2024 | $ 0.85 Million |
Turkey Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9% |
Nigeria Capsule Endoscopy Sales Revenue 2024 | $ 1.03 Million |
Nigeria Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.6% |
Egypt Capsule Endoscopy Sales Revenue 2024 | $ 1.03 Million |
Egypt Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 9.8% |
South Africa Capsule Endoscopy Sales Revenue 2024 | $ 1.55 Million |
South Africa Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.5% |
GCC Countries Capsule Endoscopy Sales Revenue 2024 | $ 4.21 Million |
GCC Countries Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 10.3% |
Rest of MEA Capsule Endoscopy Sales Revenue 2024 | $ 1.16 Million |
Rest of MEA Capsule Endoscopy Compound Annual Growth Rate (CAGR) for 2024 to 2031 | 8.5% |
Market Drivers:
| |
Market Restrains:
| |
Market Trends:
|
Market Split by Type Outlook: |
|
Market Split by Application Outlook: |
|
Market Split by Component Outlook: |
|
Market Split by Endoscope Type Outlook: |
|
Market Split by End User Outlook: |
|
List of Competitors |
|
Regional Analysis |
|
Country Analysis |
|
Report scope is customizable as we have a huge database of Capsule Endoscopy industry. We can deliver an exclusive report Edition/Consultation as per your data requirements. Request for your Free Sample Pages.
Capsule Endoscopy Market is Segmented as below. Particular segment of your interest can be provided without any additional cost. Download the Sample Pages!
Capsule endoscopy refers to a diagnostic procedure used for obtaining images of the esophagus, stomach, and small intestines. It involves the use of a small capsule-encased camera, which is swallowed and passed through the gastrointestinal (GI) tract. The procedure is minimally invasive (MI), painless, and does not require the administration of anesthesia. It enables the physician to take thousands of images of the internal organs which are not accessible through the traditionally used imaging solutions. As a result, capsule endoscopy is widely used in the diagnosis and treatment of gastrointestinal cancer, chronic abdominal pain, Crohn’s disease, celiac disease, excessive bleeding, and ulcers. This market has experienced rapid growth in recent years due to increasing incidences of GI diseases, advancements in technology, and a global shift toward less invasive diagnostic procedures. Unlike conventional endoscopy, capsule endoscopy requires no sedation, allowing patients to perform the test with minimal discomfort and interruption to daily activities. The aging global population, a rise in lifestyle-related GI disorders, and growing awareness of preventive healthcare have further driven the demand for capsule endoscopy
In November 2021, Medtronic plc announced that it received FDA approval for its PillCam device for remote endoscopic procedures. The PillCam SB3 program integrates Medtronic’s PillCam technology with Amazon logistics, enabling patients to obtain fast and accurate diagnostic results from the comfort of their own homes. (Source: https://news.medtronic.com/2021-11-15-Medtronic-announces-510-k-clearance-for-PillCam-TM-Small-Bowel-3-HOME-endoscopy-procedure )
The growing prevalence of gastrointestinal diseases, including Crohn’s disease, ulcerative colitis, small bowel tumors, gastrointestinal bleeding, and celiac disease, is a key driver for the capsule endoscopy market. As the global population ages, especially in developed countries, the susceptibility to GI disorders increases, amplifying the demand for advanced diagnostic tools like capsule endoscopy. By 2030, it is projected that one in six people worldwide will be over the age of 60, with the population of those aged 60 and above rising from 1 billion in 2020 to 1.4 billion. By 2050, the number of individuals aged 60 and older is expected to double, reaching 2.1 billion. Additionally, the number of people aged 80 and above is set to triple from 2020 to 2050, reaching 426 million. In 2022, 2.5 billion adults aged 18 and older were classified as overweight, including over 890 million living with obesity, which accounts for 43% of adults globally. This marks an increase from 1990 when 25% of adults were overweight. Furthermore, the rise in lifestyle-related diseases such as obesity, poor diet, and stress is contributing to the growing incidence of GI conditions, thereby driving the demand for capsule endoscopy.
Although capsule endoscopy was initially developed for examining the small intestine, its applications have expanded to include other parts of the GI tract, such as the colon and esophagus. Colon capsule endoscopy, for example, is gaining traction as a non-invasive alternative for colorectal cancer screening, which is particularly beneficial for patients who may not be able to tolerate traditional colonoscopy. As new applications emerge, the potential patient base for capsule endoscopy expands, creating additional demand for the technology across various GI diagnostic areas.
Capsule endoscopy systems are relatively expensive when compared to traditional endoscopy devices. The cost of the capsule itself, as well as the necessary infrastructure (e.g., data recording and analysis systems), can be a financial barrier for healthcare facilities, especially in low- and middle-income regions. The cost of the procedure itself, including professional fees for administering the capsule and interpreting the data, can be higher than that of traditional endoscopy or imaging methods, limiting accessibility for some patient groups. These high costs could discourage adoption, particularly in developing countries, where healthcare budgets are more constrained, and reimbursement policies may be limited. While capsule endoscopy is less invasive than traditional methods, patient compliance can still be an issue. For example, the patient must swallow the capsule, which may be uncomfortable for some people, especially children or those with swallowing difficulties.
During the early phases of the COVID-19 pandemic, healthcare systems globally were overwhelmed, focusing primarily on treating COVID-19 patients. This led to the postponement or cancellation of many elective and non-emergency procedures, including capsule endoscopy for routine gastrointestinal (GI) diagnoses. Despite the initial decline, the need for non-invasive, at-home diagnostic solutions rose as patients avoided hospitals and clinics to reduce COVID-19 exposure. Capsule endoscopy, being minimally invasive and capable of remote data transmission, provided a safer diagnostic alternative to traditional procedures like colonoscopy and gastroscopy. COVID-19 emphasized the importance of preventive healthcare and early diagnosis, as delays in diagnosing chronic and serious illnesses can lead to severe outcomes. This awareness has increased the focus on early detection of GI diseases, particularly as healthcare systems aim to prevent patient overload and reduce severe GI cases.
We have various report editions of Capsule Endoscopy Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.
In the Capsule Endoscopy market's competitive landscape, numerous key competitors are driving innovation and growth. Major companies are heavily investing in research and development to enhance device performance, particularly in image quality, battery life, and data analysis features. Many companies are incorporating AI algorithms to automate image analysis, aiding in faster and more accurate diagnostics. Improved battery life and smaller capsule sizes are also areas of focus to enhance comfort and effectiveness.
In June 2018, CapsoVision announced a strategic partnership with PENTAX Medical to distribute CapsoCam Plus in the U.S. This collaboration aims to expand CapsoVision's customer base and boost its business revenue. (Source: https://capsovision.com/capsovision-announces-u-s-distribution-partnership-with-pentax-medical/ )
Top Companies Market Share in Capsule Endoscopy Industry: (In no particular order of Rank)
If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.
According to Cognitive Market Research, North America currently dominates the Capsule Endoscopy market, and the region is expected to have significant growth during the projected period. North America is significantly impacted by gastrointestinal (GI) disorders, including Crohn's disease, colorectal cancer, celiac disease, and gastrointestinal bleeding. The Centers for Disease Control and Prevention (CDC) identifies colorectal cancer as one of the most prevalent cancers in the United States, and millions are affected by inflammatory bowel disease (IBD). In Canada, the number of people with IBD is rising rapidly, from 322,600 individuals in 2023 (0.8% of the population) to a projected 470,000 by 2035 (1.1% of the population). In 2023, approximately 11,000 new cases will be diagnosed (one every 48 minutes), increasing to 14,000 by 2035 (one every 38 minutes). Capsule endoscopy, being a less invasive and highly effective diagnostic tool, is increasingly adopted for managing these conditions across the region.
Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The Asia Pacific region is undergoing a demographic shift, with a notable increase in the elderly population, especially in countries such as Japan, China, and South Korea. Older adults face a heightened risk of GI disorders, making capsule endoscopy an invaluable tool for early and precise diagnosis. Currently, Asia has approximately 649 million people aged 60 and above, accounting for 58% of the global senior population. Over the next three decades, this segment’s proportion of the total population (currently 13.7%) and its absolute number are set to double, reaching 1.3 billion, or 25% of Asia’s population by 2050. In India, 149 million individuals aged 60 and older, representing around 10.5% of the population in 2022, are projected to grow to 347 million by 2050, making up 20.8% of the population. As the demand for healthcare services tailored to the needs of an aging population rises, so does the need for minimally invasive diagnostic solutions that provide ease and comfort.
The current report Scope analyzes Capsule Endoscopy Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com
The above graph is for illustrative purposes only.
To learn more about geographical trends request the free sample pages.
Get Free Sample
According to Cognitive Market Research, the global Capsule Endoscopy market size was estimated at USD 491.6 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 196.64 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.0% from 2024 to 2031.
According to Cognitive Market Research, the global Capsule Endoscopy market size was estimated at USD 491.6 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 147.48 million in 2024 and will grow at a compound annual growth rate (CAGR) of 8.34% from 2024 to 2031.
According to Cognitive Market Research, the global Capsule Endoscopy market size was estimated at USD 491.6 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 113.07 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.8% from 2024 to 2031.
According to Cognitive Market Research, the global Capsule Endoscopy market size was estimated at USD 491.6 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 24.58 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.2% from 2024 to 2031.
According to Cognitive Market Research, the global Capsule Endoscopy market size was estimated at USD 491.6 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 9.83 million in 2024 and will grow at a compound annual growth rate (CAGR) of 9.5% from 2024 to 2031.
Global Capsule Endoscopy Market Report 2024 Edition talks about crucial market insights with the help of segments and sub-segments analysis. In this section, we reveal an in-depth analysis of the key factors influencing Capsule Endoscopy Industry growth. Capsule Endoscopy market has been segmented with the help of its Type Outlook:, Application Outlook: Component Outlook:, and others. Capsule Endoscopy market analysis helps to understand key industry segments, and their global, regional, and country-level insights. Furthermore, this analysis also provides information pertaining to segments that are going to be most lucrative in the near future and their expected growth rate and future market opportunities. The report also provides detailed insights into factors responsible for the positive or negative growth of each industry segment.
How are Segments Performing in the Global Capsule Endoscopy Market?
According to Cognitive Market Research, Small Bowel capsules are likely to dominate the Capsule Endoscopy Market over the forecast period. The small intestine is often challenging to diagnose using traditional endoscopic techniques due to its length and location, which limits the ability of conventional endoscopes to access and visualize it. Small bowel capsule endoscopy, however, allows for a non-invasive and comprehensive view of the entire small intestine. It is highly effective in diagnosing a range of small bowel disorders, such as Crohn’s disease, small bowel tumors, celiac disease, gastrointestinal bleeding, and obscure GI bleeding (where the source of bleeding is unknown). The ability to accurately assess the small intestine without the need for surgical procedures or lengthy hospital stays makes small bowel capsule endoscopy a preferred diagnostic tool.
Esophageal Capsule is the fastest-growing segment in the Capsule Endoscopy Market. The esophagus is a critical part of the digestive system, and conditions affecting it, such as esophageal cancer, gastroesophageal reflux disease (GERD), esophageal varices, achalasia, esophagitis, and Barrett’s esophagus, can significantly impact a patient’s health. Diagnosing these conditions can be challenging using traditional methods like endoscopy or X-rays, which are either invasive or have limitations in certain areas. Esophageal capsule endoscopy, however, offers a non-invasive solution that allows for a thorough examination of the esophagus, making it a preferred diagnostic tool for many of these conditions.
The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Capsule Endoscopy Industry. Request a Free Sample PDF!
According to Cognitive Market Research, The Crohn’s Disease segment holds the largest market share. Crohn’s disease, a type of inflammatory bowel disease (IBD), is a chronic condition that causes inflammation of the digestive tract, often affecting the small intestine and colon. The global incidence of Crohn’s disease has been rising in both developed and emerging markets. According to research, the incidence of IBD, including Crohn’s disease, has been steadily increasing in countries such as the United States, Canada, and parts of Europe. Additionally, the condition is also becoming more common in Asia and Latin America as lifestyles and dietary patterns change. The growing prevalence of Crohn’s disease is directly contributing to the demand for diagnostic tools, with capsule endoscopy emerging as a preferred method due to its non-invasive nature and ability to visualize the small intestine, which is often challenging to examine with traditional endoscopy methods.
In the Capsule Endoscopy market, the rapidly growing sector is the Intestine Disease category. The increasing global prevalence of intestinal diseases, including conditions like Crohn’s disease, ulcerative colitis, gastrointestinal bleeding, small bowel tumors, celiac disease, and inflammatory bowel diseases (IBD), is a key driver for the growth of the intestine disease application segment. These diseases are becoming more common in both developed and developing regions due to changing lifestyles, dietary habits, and aging populations. Small bowel tumors are also on the rise, and detecting them early is critical to improving patient outcomes. Capsule endoscopy offers a non-invasive way to detect abnormalities in the small intestine.
The above Graph is for representation purposes only. This chart does not depict actual Market share.
To learn more about market share request the free sample pages.
Get Free Sample
According to Cognitive Market Research, The Wireless Capsule Endoscopy segment holds the largest market share. Wireless capsule endoscopes now feature higher-resolution cameras that provide clearer and more detailed images of the GI tract, including the small intestine, which is difficult to reach with traditional endoscopic methods. This improves the ability to detect small lesions, tumors, ulcers, and bleeding sources in hard-to-reach areas, particularly in the small bowel. Wireless capsule endoscopy is non-invasive, requires no sedation, and does not involve any incisions or insertions, unlike traditional endoscopic procedures like colonoscopies or upper GI endoscopies. These advantages make wireless capsule endoscopy increasingly appealing to both patients and healthcare providers.
In the Capsule Endoscopy market, the rapidly growing sector is the Capsule Endoscopy Data Recorder category. One of the primary factors contributing to the growth of the Capsule Endoscopy Data Recorder segment is the significant technological advancements in data recording systems. Over the past few years, there have been improvements in the ability to record, store, and process high-resolution images transmitted by the capsule in real time. These advancements have made the data recorder a critical component in the diagnostic process, helping to enhance the effectiveness and accuracy of capsule endoscopy procedures. The growth in data volume generated by capsule endoscopy devices has led to improved storage capabilities in data recorders. These recorders can now store large volumes of image data without compromising image quality or data integrity. This feature is essential for recording extended procedures, which are increasingly common in patients with complicated GI conditions.
According to Cognitive Market Research, The Capsule Cystoscopies segment holds the largest market share. The increasing incidence of urological disorders, such as bladder cancer, urinary tract infections (UTIs), bladder stones, and interstitial cystitis, has significantly contributed to the growth of the capsule cystoscopy segment. The demand for non-invasive diagnostic techniques in urology has increased as patients and healthcare providers seek alternatives to traditional cystoscopy procedures. Capsule cystoscopy is particularly useful for detecting bladder cancer, which is one of the most common cancers in the urinary system. Early diagnosis is crucial for effective treatment, and capsule cystoscopy offers a non-invasive, efficient method for screening and monitoring bladder cancer.
In the Capsule Endoscopy market, the rapidly growing segment is the Capsule Neuro-Endoscopes category. The increasing prevalence of neurological conditions, such as brain tumors, spinal cord diseases, epilepsy, and neurodegenerative disorders, is driving the demand for more effective and less invasive diagnostic methods. Traditional methods, such as MRI and CT scans, while highly effective, may not always offer the precision needed for specific neurological conditions, and often require the patient to undergo invasive procedures. Capsule neuro-endoscopes are valuable in detecting abnormalities such as tumors in the brain and spinal cord, which often require early diagnosis for effective treatment. Traditional biopsy or imaging methods might not always be able to provide real-time, detailed visual information, making capsule neuro-endoscopy an attractive option.
According to Cognitive Market Research, The Diagnostic Centers segment holds the largest market share. As patients and healthcare providers continue to prioritize minimally invasive procedures, capsule endoscopy has become a preferred diagnostic tool, especially in diagnostic centers. Capsule endoscopy offers several advantages over traditional endoscopic procedures, such as colonoscopies and gastroscopies, which may involve discomfort, sedation, and a higher risk of complications. As patients and healthcare providers continue to prioritize minimally invasive procedures, capsule endoscopy has become a preferred diagnostic tool, especially in diagnostic centers. Capsule endoscopy offers several advantages over traditional endoscopic procedures, such as colonoscopies and gastroscopies, which may involve discomfort, sedation, and a higher risk of complications.
In the Capsule Endoscopy market, the rapidly growing segment is the Clinics & Hospitals category. As healthcare systems globally shift toward preventive care and early diagnosis, capsule endoscopy plays a crucial role in enabling healthcare providers, particularly clinics and hospitals, to meet this demand. The ability to detect GI issues early can lead to better patient outcomes and lower long-term treatment costs. Hospitals and clinics are increasingly adopting capsule endoscopy for screening purposes, particularly for high-risk populations such as individuals with a family history of colorectal cancer or inflammatory bowel disease. Early detection through capsule endoscopy allows for timely intervention and reduces the risk of disease progression.
Senior Research Associate at Cognitive Market Research
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over 3+ years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies. Her expertise lies in the ability to analyze complex data sets and deliver insights that drive business decisions. At Cognitive Market Research, she handles the market research related to Pharma and healthcare industry.
Manjiri Kanhere is an experienced market researcher focused on the Pharma & Healthcare industry. With over three years of experience, She has worked with major pharmaceutical companies and healthcare providers, helping them to understand market trends, identify new business opportunities, and develop effective sales & marketing strategies.
In her current role, Manjiri handles the market research related to Pharma and healthcare industry. Her passion lies in utilizing innovative approaches to distill complex information into strategic insights that empower organizations to make informed decisions.Manjiri remains an invaluable asset in the dynamic landscape of market research.
Conclusion
Please note, we have not disclose, all the sources consulted/referred during a market study due to confidentiality and paid service concern. However, rest assured that upon purchasing the service or paid report version, we will release the comprehensive list of sources along with the complete report and we also provide the data support where you can intract with the team of analysts who worked on the report.
Disclaimer:
Type Outlook: | Small Bowel Capsule, Esophageal Capsule, Colon Capsule |
Application Outlook: | Intestine Disease, Crohn’s Disease, GIT Bleeding, Others |
Component Outlook: | Wireless Capsule Endoscopy, Capsule Endoscopy Data Recorder, Capsule Endoscopy Workstations |
Endoscope Type Outlook: | Capsule Cystoscopies, Capsule Neuro-Endoscopes |
End User Outlook: | Diagnostic Centers, Clinics & Hospitals, Medical Research Institutes, Others |
List of Competitors | Shangxian Minimal Invassive Inc., IntroMedic Co., MEDTRONIC PLC., Fujifilm Holding Corporation, Olympus Corporation, Anx Robotica, Chongqing Jinshan Science and Technology Group Co., CapsoVision Inc., Check-Cap, RF Systems Lab, Given Imaging (Medtronic Plc), RF System lab |
This chapter will help you gain GLOBAL Market Analysis of Capsule Endoscopy. Further deep in this chapter, you will be able to review Global Capsule Endoscopy Market Split by various segments and Geographical Split.
Chapter 1 Global Market Analysis
Global Market has been segmented on the basis 5 major regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America.
You can purchase only the Executive Summary of Global Market (2019 vs 2024 vs 2031)
Global Market Dynamics, Trends, Drivers, Restraints, Opportunities, Only Pointers will be deliverable
This chapter will help you gain North America Market Analysis of Capsule Endoscopy. Further deep in this chapter, you will be able to review North America Capsule Endoscopy Market Split by various segments and Country Split.
Chapter 2 North America Market Analysis
This chapter will help you gain Europe Market Analysis of Capsule Endoscopy. Further deep in this chapter, you will be able to review Europe Capsule Endoscopy Market Split by various segments and Country Split.
Chapter 3 Europe Market Analysis
This chapter will help you gain Asia Pacific Market Analysis of Capsule Endoscopy. Further deep in this chapter, you will be able to review Asia Pacific Capsule Endoscopy Market Split by various segments and Country Split.
Chapter 4 Asia Pacific Market Analysis
This chapter will help you gain South America Market Analysis of Capsule Endoscopy. Further deep in this chapter, you will be able to review South America Capsule Endoscopy Market Split by various segments and Country Split.
Chapter 5 South America Market Analysis
This chapter will help you gain Middle East and Africa Market Analysis of Capsule Endoscopy. Further deep in this chapter, you will be able to review Middle East and Africa Capsule Endoscopy Market Split by various segments and Country Split.
Chapter 6 Middle East and Africa Market Analysis
Only Available with Corporate User License
Chapter 7 Top 10 Countries Analysis (Only Available with Corporate User License)
This chapter provides an in-depth analysis of the market share among key competitors of Capsule Endoscopy. The analysis highlights each competitor's position in the market, growth trends, and financial performance, offering insights into competitive dynamics, and emerging players.
Chapter 8 Competitor Analysis (Subject to Data Availability (Private Players))
(Subject to Data Availability (Private Players))
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
Data Subject to Availability as we consider Top competitors and their market share will be delivered.
This chapter would comprehensively cover market drivers, trends, restraints, opportunities, and various in-depth analyses like industrial chain, PESTEL, Porter’s Five Forces, and ESG, among others. It would also include product life cycle, technological advancements, and patent insights.
Chapter 9 Qualitative Analysis (Subject to Data Availability)
Segmentation Type Outlook: Analysis 2019 -2031, will provide market size split by Type Outlook:. This Information is provided at Global Level, Regional Level and Top Countries Level The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 10 Market Split by Type Outlook: Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 11 Market Split by Application Outlook: Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 12 Market Split by Component Outlook: Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 13 Market Split by Endoscope Type Outlook: Analysis 2019 -2031
The report with the segmentation perspective mentioned under this chapters will be delivered to you On Demand. So please let us know if you would like to receive this additional data as well. No additional cost will be applicable for the same.
Chapter 14 Market Split by End User Outlook: Analysis 2019 -2031
This chapter helps you understand the Key Takeaways and Analyst Point of View of the global Capsule Endoscopy market
Chapter 15 Research Findings
Here the analyst will summarize the content of entire report and will share his view point on the current industry scenario and how the market is expected to perform in the near future. The points shared by the analyst are based on his/her detailed in-depth understanding of the market during the course of this report study. You will be provided exclusive rights to interact with the concerned analyst for unlimited time pre purchase as well as post purchase of the report.
Why Small Bowel Capsule have a significant impact on Capsule Endoscopy market? |
What are the key factors affecting the Small Bowel Capsule and Esophageal Capsule of Capsule Endoscopy Market? |
What is the CAGR/Growth Rate of Intestine Disease during the forecast period? |
By type, which segment accounted for largest share of the global Capsule Endoscopy Market? |
Which region is expected to dominate the global Capsule Endoscopy Market within the forecast period? |
Segmentation Level Customization |
|
Global level Data Customization |
|
Region level Data Customization |
|
Country level Data Customization |
|
Company Level |
|
Additional Data Analysis |
|
Additional Qualitative Data |
|
Additional Quantitative Data |
|
Service Level Customization |
|
Report Format Alteration |
|
Published Report Editions
are Just a Tip of an Iceberg
Access the Complete Database of
Capsule Endoscopy Market
Request Sample